# ZNF577

## Overview
ZNF577 is a gene that encodes the zinc finger protein 577, which is part of the zinc finger protein family known for their role in transcriptional regulation. Zinc finger proteins typically function as transcription factors, binding to DNA and influencing the expression of various genes. ZNF577 has been implicated in several biological processes and diseases, including cancer and neurological disorders. The protein is involved in pathways related to RNA processing and intracellular signaling, which are crucial in the pathogenesis of diseases such as amyotrophic lateral sclerosis (ALS) and various cancers (Morello2023A; Sun2020Genome-wide). Additionally, ZNF577 is subject to epigenetic modifications, such as DNA methylation, which can alter its expression and function, making it a potential biomarker for disease diagnosis and prognosis (Crujeiras2017Obesity; Zhang2017Comprehensive).

## Structure


## Clinical Significance
ZNF577 has been implicated in several diseases, primarily through alterations in its methylation and expression levels. In breast cancer, ZNF577 is significantly hypermethylated in tumor samples, particularly in postmenopausal obese women, suggesting its role as an epigenetic marker for high-risk breast cancer. This hypermethylation is associated with decreased gene expression, indicating a potential mechanism for cancer progression (Crujeiras2017Obesity; Lorenzo2020ZNF577). The methylation status of ZNF577 can distinguish between tumor and non-tumor samples with high accuracy, highlighting its potential as a biomarker for breast cancer detection and risk stratification (Crujeiras2017Obesity).

In lung adenocarcinoma, ZNF577 also shows high methylation levels, correlating with decreased expression, which may contribute to tumorigenesis. However, its role in lung cancer requires further investigation to confirm its clinical significance (Zhang2017Comprehensive).

ZNF577 has been identified as a differentially expressed gene in amyotrophic lateral sclerosis (ALS), where it may contribute to pathogenesis by interacting with RNA-binding proteins and altering DNA damage repair processes (Morello2023A). These findings suggest that ZNF577 could be a target for therapeutic interventions in these diseases.

## Interactions
ZNF577, a zinc finger protein, is involved in various interactions that may influence its role in transcriptional regulation and disease pathology. In the context of amyotrophic lateral sclerosis (ALS), ZNF577 has been identified as a hub gene in a protein-protein interaction (PPI) network, suggesting its significant role in cellular processes related to ALS. This network analysis, conducted using the STRING database, highlights ZNF577's involvement in pathways such as RNA processing and intracellular signaling, which are crucial in ALS pathogenesis (Morello2023A).

In cancer research, ZNF577 has been associated with alternative splicing events and DNA methylation changes across various tumor types, including head and neck squamous cell carcinoma and prostate adenocarcinoma. These modifications may affect ZNF577's interactions with other proteins or nucleic acids, potentially influencing cancer progression and serving as prognostic biomarkers (Sun2020Genome-wide).

While specific protein interactions involving ZNF577 are not detailed in the provided context, its role as a zinc finger protein suggests potential interactions with RNA-binding proteins and involvement in transcriptional regulation processes, which may be critical in both neurological and oncological contexts (Morello2023A; Sun2020Genome-wide).


## References


[1. (Lorenzo2020ZNF577) Paula M. Lorenzo, Andrea G. Izquierdo, Angel Diaz-Lagares, Marcos C. Carreira, Manuel Macias-Gonzalez, Juan Sandoval, Juan Cueva, Rafael Lopez-Lopez, Felipe F. Casanueva, and Ana B. Crujeiras. Znf577 methylation levels in leukocytes from women with breast cancer is modulated by adiposity, menopausal state, and the mediterranean diet. Frontiers in Endocrinology, April 2020. URL: http://dx.doi.org/10.3389/fendo.2020.00245, doi:10.3389/fendo.2020.00245. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2020.00245)

[2. (Sun2020Genome-wide) Xiaohui Sun, Yiping Tian, Jianming Wang, Zeyuan Sun, and Yimin Zhu. Genome-wide analysis reveals the association between alternative splicing and dna methylation across human solid tumors. BMC Medical Genomics, January 2020. URL: http://dx.doi.org/10.1186/s12920-019-0654-9, doi:10.1186/s12920-019-0654-9. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12920-019-0654-9)

[3. (Crujeiras2017Obesity) Ana B Crujeiras, Angel Diaz-Lagares, Olafur A Stefansson, Manuel Macias-Gonzalez, Juan Sandoval, Juan Cueva, Rafael Lopez-Lopez, Sebastian Moran, Jon G Jonasson, Laufey Tryggvadottir, Elinborg Olafsdottir, Francisco J Tinahones, Marcos C Carreira, Felipe F Casanueva, and Manel Esteller. Obesity and menopause modify the epigenomic profile of breast cancer. Endocrine-Related Cancer, pages 351–363, July 2017. URL: http://dx.doi.org/10.1530/erc-16-0565, doi:10.1530/erc-16-0565. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1530/erc-16-0565)

[4. (Morello2023A) Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Vincenzo La Bella, Francesca Luisa Conforti, and Sebastiano Cavallaro. A diagnostic gene-expression signature in fibroblasts of amyotrophic lateral sclerosis. Cells, 12(14):1884, July 2023. URL: http://dx.doi.org/10.3390/cells12141884, doi:10.3390/cells12141884. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12141884)

[5. (Zhang2017Comprehensive) Yunfeng Zhang, Weidong Zhao, and Jia Zhang. Comprehensive epigenetic analysis of the signature genes in lung adenocarcinoma. Epigenomics, 9(9):1161–1173, August 2017. URL: http://dx.doi.org/10.2217/epi-2017-0023, doi:10.2217/epi-2017-0023. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/epi-2017-0023)